3-iodobenzylguanidine has been researched along with Granuloma, Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballinger, JR | 1 |
| Howman-Giles, R; Shaw, PJ; Uren, RF | 1 |
1 review(s) available for 3-iodobenzylguanidine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Theranostic radiopharmaceuticals: established agents in current use.
Topics: 3-Iodobenzylguanidine; Antigens, CD20; Bone Neoplasms; Dipeptides; Diphosphonates; Drug Approval; Forecasting; Heterocyclic Compounds, 1-Ring; Hodgkin Disease; Humans; Iodine Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Prostate-Specific Antigen; Radiopharmaceuticals; Somatostatin; Theranostic Nanomedicine; Thyroid Diseases | 2018 |
1 other study(ies) available for 3-iodobenzylguanidine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Topics: 3-Iodobenzylguanidine; Child; Female; Gallium Radioisotopes; Hodgkin Disease; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphoma, Non-Hodgkin; Male; Neuroblastoma; Radionuclide Imaging; Rhabdomyosarcoma; Soft Tissue Neoplasms; Thallium Radioisotopes; Wilms Tumor | 1995 |